pmid,title,journal,year,drug,disease
40014859,Prediction of Hepatitis C Virus Perinatal Transmission in Pregnant Individuals With Hepatitis C Virus Infection.,Obstetrics and gynecology,2025,Paxlovid,Hepatitis C
39144220,Curing of chronic hepatitis C combined with coronavirus disease 2019 in a couple over 85 years old: a case series study.,Frontiers in microbiology,2024,Paxlovid,Hepatitis C
38621119,Proof-of-concept studies with a computationally designed M(pro) inhibitor as a synergistic combination regimen alternative to Paxlovid.,Proceedings of the National Academy of Sciences of the United States of America,2024,Paxlovid,Hepatitis C
38438015,The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance.,Antiviral research,2024,Paxlovid,Hepatitis C
38176013,"Breastfeeding Initiation, Duration, and Associated Factors Among People With Hepatitis C Virus Infection.",Obstetrics and gynecology,2024,Paxlovid,Hepatitis C
37555275,A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants.,Emerging microbes & infections,2023,Paxlovid,Hepatitis C
36459838,Viral proteases as therapeutic targets.,Molecular aspects of medicine,2022,Paxlovid,Hepatitis C
35899636,"[Prise en charge medicale du Covid-19, hors reanimation].",La Revue du praticien,2022,Paxlovid,Hepatitis C
